Monitoring and Peer Support to Improve Treatment Adherence and Outcomes
O2VERLAP
1 other identifier
interventional
294
1 country
1
Brief Summary
The O2VERLAP study investigators would like to find out if individuals living with both COPD and OSA would benefit from an online, educational curriculum, coupled with access to peer support (i.e. telephone and online chatting with peers) and remote CPAP adherence monitoring data. The curriculum and peer coaching is meant to provide participants the information and tools they need to be more compliant in using their CPAP device.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable chronic-obstructive-pulmonary-disease
Started Feb 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 15, 2018
CompletedStudy Start
First participant enrolled
February 1, 2018
CompletedFirst Posted
Study publicly available on registry
February 27, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2019
CompletedResults Posted
Study results publicly available
December 3, 2021
CompletedDecember 3, 2021
October 1, 2021
1.7 years
January 15, 2018
September 30, 2021
October 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in CPAP Adherence at 6 Weeks
CPAP adherence is being measured through remote adherence monitoring of all participants; the study inclusion criteria requires all participants be using a CPAP device with wireless modem, the wireless modem allows the study investigators to accurately measure participants CPAP usage daily. Participants CPAP device record the 'total time connected' each day or total time the device is being used (i.e. units are hours per day). Study investigators will retroactively access and collect 30-days of baseline adherence data, prior to randomization, to measure the participants level of baseline adherence. The study investigators will then track participants total time using their CPAP device in hours, each day, for the duration of the participants enrollment (i.e. about three months).
6 weeks
Secondary Outcomes (1)
Change in Daytime Functioning at 6 and12 Weeks
6 weeks and 12 weeks
Other Outcomes (1)
Change in Sleep Quality at 6 and 12 Weeks
6 weeks and 12 weeks
Study Arms (2)
Reactive Care (RC)
ACTIVE COMPARATORParticipants in the RC arm of the study will be provided access to the COPD Information Line if they feel they would benefit from the support of a peer health coach. Peer health coaches working the information line are patients also living with COPD who can offer peer level support.
Proactive Care (PC)
ACTIVE COMPARATORParticipants in the PC arm of the study will be provided access to the COPD Information Line if they feel they would benefit from the support of a peer health coach. Peer health coaches working the information line are patients also living with COPD who can offer peer level support. Additionally, the PC group will also receive access to an online study portal which houses an educational health curriculum covering topics related to COPD and OSA. The portal allows participants to send online messages to peer coaches and respiratory therapist coaches. PC group will also receive weekly updates.
Interventions
Access to educational and informational support by a trained peer coach
An online platform that provides educational, informational and access to several therapeutic device metrics
Limited medical support provided by trained Respiratory Therapists.
Eligibility Criteria
You may qualify if:
- Age: \>40 years
- Primary language: English
- Diagnosed with both Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea (OSA)
- Prescription for positive airway pressure therapy (PAP). There should be no minimum or maximum flow required (i.e., no limitation on PAP modality).
- Access to the internet viand a PC, tablet, or smart phone to complete all study activities from home or remotely
- PAP device with wireless modem
You may not qualify if:
- Non-English speakers
- Life expectancy less than or equal to six months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- COPD Foundationlead
Study Sites (1)
COPD Foundation Inc.
Miami, Florida, 33134, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
The study utilized a national, electronic only recruitment method, which was primarily focused on the chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) communities. This may have resulted in a sample of participants who are more actively involved online seeking information and support for their medical condition. Future studies would benefit from recruiting a more diverse sample of patients on a number of dimensions.
Results Point of Contact
- Title
- Carl Stepnowsky, PhD
- Organization
- University of California, San Diego, La Jolla, CA
Study Officials
- PRINCIPAL INVESTIGATOR
Carl Stepnowsky, PhD
University of California, San Diego
- PRINCIPAL INVESTIGATOR
Elisha Malanga, BS
COPD Foundation
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 15, 2018
First Posted
February 27, 2018
Study Start
February 1, 2018
Primary Completion
October 31, 2019
Study Completion
October 31, 2019
Last Updated
December 3, 2021
Results First Posted
December 3, 2021
Record last verified: 2021-10